Julia D. Suerth

715 total citations
14 papers, 593 citations indexed

About

Julia D. Suerth is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Julia D. Suerth has authored 14 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Genetics and 6 papers in Oncology. Recurrent topics in Julia D. Suerth's work include Virus-based gene therapy research (12 papers), CRISPR and Genetic Engineering (10 papers) and RNA Interference and Gene Delivery (7 papers). Julia D. Suerth is often cited by papers focused on Virus-based gene therapy research (12 papers), CRISPR and Genetic Engineering (10 papers) and RNA Interference and Gene Delivery (7 papers). Julia D. Suerth collaborates with scholars based in Germany, United States and France. Julia D. Suerth's co-authors include Axel Schambach, Stephan Kloeß, Ulrike Koehl, Christopher Baum, Manuel Grez, Wolfgang Glienke, Ruth Esser, Lubomir Arseniev, Christoph Priesner and Winfried S. Wels and has published in prestigious journals such as PLoS ONE, Biomaterials and Journal of Virology.

In The Last Decade

Julia D. Suerth

14 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julia D. Suerth Germany	14	395	297	278	270	40	14	593
Mark Enstrom United States	7	183 0.5×	99 0.3×	184 0.7×	113 0.4×	47 1.2×	15	335
Justin C. Boucher United States	12	398 1.0×	254 0.9×	162 0.6×	131 0.5×	56 1.4×	31	571
Minhtran Ngo United States	8	452 1.1×	328 1.1×	174 0.6×	230 0.9×	50 1.3×	9	633
Jamal Alzubi Germany	11	199 0.5×	129 0.4×	290 1.0×	122 0.5×	10 0.3×	20	452
R. L. H. Bolhuis Netherlands	10	424 1.1×	397 1.3×	133 0.5×	169 0.6×	11 0.3×	15	585
Elisa Kieback Germany	10	544 1.4×	444 1.5×	185 0.7×	273 1.0×	24 0.6×	15	697
Michela Cesco-Gaspere United Kingdom	11	237 0.6×	229 0.8×	108 0.4×	138 0.5×	20 0.5×	15	366
Victoria Tobin United States	5	273 0.7×	186 0.6×	441 1.6×	131 0.5×	8 0.2×	5	615
Dan D. Vo United States	9	223 0.6×	179 0.6×	176 0.6×	65 0.2×	20 0.5×	10	389
Carla Fowler United States	5	342 0.9×	325 1.1×	128 0.5×	147 0.5×	10 0.3×	6	456

Countries citing papers authored by Julia D. Suerth

Since Specialization

Citations

This map shows the geographic impact of Julia D. Suerth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia D. Suerth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia D. Suerth more than expected).

Fields of papers citing papers by Julia D. Suerth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia D. Suerth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia D. Suerth. The network helps show where Julia D. Suerth may publish in the future.

Co-authorship network of co-authors of Julia D. Suerth

This figure shows the co-authorship network connecting the top 25 collaborators of Julia D. Suerth. A scholar is included among the top collaborators of Julia D. Suerth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia D. Suerth. Julia D. Suerth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Klatt, Denise, Dirk Hoffmann, Julia D. Suerth, et al.. (2022). Improved alpharetrovirus-based Gag.MS2 particles for efficient and transient delivery of CRISPR-Cas9 into target cells. Molecular Therapy — Nucleic Acids. 27. 810–823. 13 indexed citations

Suerth, Julia D., Dirk Heckl, Camille Lévy, et al.. (2016). Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes. Biomaterials. 97. 97–109. 13 indexed citations

Suerth, Julia D., Dirk Hoffmann, Jessica Herbst, et al.. (2016). Generation of Genetically Engineered Precursor T-Cells From Human Umbilical Cord Blood Using an Optimized Alpharetroviral Vector Platform. Molecular Therapy. 24(7). 1216–1226. 20 indexed citations

Suerth, Julia D., Michael Morgan, Stephan Kloeß, et al.. (2015). Efficient generation of gene-modified human natural killer cells via alpharetroviral vectors. Journal of Molecular Medicine. 94(1). 83–93. 69 indexed citations

Glienke, Wolfgang, Ruth Esser, Christoph Priesner, et al.. (2015). Advantages and applications of CAR-expressing natural killer cells. Frontiers in Pharmacology. 6. 21–21. 200 indexed citations

Kuehle, Johannes, Soeren Turan, Tobias Cantz, et al.. (2014). Modified Lentiviral LTRs Allow Flp Recombinase–mediated Cassette Exchange and In Vivo Tracing of “Factor-free” Induced Pluripotent Stem Cells. Molecular Therapy. 22(5). 919–928. 20 indexed citations

Suerth, Julia D., et al.. (2014). Alpharetroviral Vectors: From a Cancer-Causing Agent to a Useful Tool for Human Gene Therapy. Viruses. 6(12). 4811–4838. 28 indexed citations

Moiani, Arianna, Julia D. Suerth, Ermanno Rizzi, et al.. (2014). Genome-Wide Analysis of Alpharetroviral Integration in Human Hematopoietic Stem/Progenitor Cells. Genes. 5(2). 415–429. 24 indexed citations

Moiani, Arianna, Annarita Miccio, Ermanno Rizzi, et al.. (2013). Deletion of the LTR Enhancer/Promoter Has No Impact on the Integration Profile of MLV Vectors in Human Hematopoietic Progenitors. PLoS ONE. 8(1). e55721–e55721. 13 indexed citations

10.

Brugman, Martijn H., Julia D. Suerth, Michael Rothe, et al.. (2013). Evaluating a Ligation-Mediated PCR and Pyrosequencing Method for the Detection of Clonal Contribution in Polyclonal Retrovirally Transduced Samples. Human Gene Therapy Methods. 24(2). 68–79. 20 indexed citations

11.

Kaufmann, Kerstin B., Christian Brendel, Julia D. Suerth, et al.. (2012). Alpharetroviral Vector-mediated Gene Therapy for X-CGD: Functional Correction and Lack of Aberrant Splicing. Molecular Therapy. 21(3). 648–661. 25 indexed citations

12.

Suerth, Julia D., Axel Schambach, & Christopher Baum. (2012). Genetic modification of lymphocytes by retrovirus-based vectors. Current Opinion in Immunology. 24(5). 598–608. 34 indexed citations

13.

Suerth, Julia D., Tobias Maetzig, Martijn H. Brugman, et al.. (2012). Alpharetroviral Self-inactivating Vectors: Long-term Transgene Expression in Murine Hematopoietic Cells and Low Genotoxicity. Molecular Therapy. 20(5). 1022–1032. 60 indexed citations

14.

Suerth, Julia D., Tobias Maetzig, Melanie Galla, Christopher Baum, & Axel Schambach. (2010). Self-Inactivating Alpharetroviral Vectors with a Split-Packaging Design. Journal of Virology. 84(13). 6626–6635. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact